Journal article
Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era
Abstract
Prior to the introduction of Haemophilus influenzae type b (Hib) conjugate vaccines, invasive Hib disease affected almost exclusively children. According to some recent studies, in the postvaccine era, adults, the elderly, and immunocompromised persons can be affected more often than children. As the production of type-specific anti-capsular polysaccharide antibodies is the major defense mechanism against Hib, individuals with defects in …
Authors
Nix EB; Hawdon N; Gravelle S; Biman B; Brigden M; Malik S; McCready W; Ferroni G; Ulanova M
Journal
mSphere, Vol. 19, No. 5, pp. 766–771
Publisher
American Society for Microbiology
Publication Date
May 2012
DOI
10.1128/cvi.05675-11
ISSN
1556-6811
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAgedAntibodies, BacterialBacterial CapsulesBlood Bactericidal ActivityDiabetes Mellitus, Type 2FemaleHaemophilus InfectionsHaemophilus VaccinesHaemophilus influenzae type bHumansImmunocompromised HostImmunoglobulin GMaleMiddle AgedMultiple MyelomaPulmonary Disease, Chronic ObstructiveRenal InsufficiencyRisk Assessment